Volume 16, Number 9—September 2010
Dispatch
Extensively Drug-Resistant Tuberculosis, Pakistan
Rumina Hasan
, Kauser Jabeen, Asho Ali, Yasraba Rafiq, Rabia Laiq, Babar Malik, Mahnaz Tanveer, Ramona Groenheit, Solomon Ghebremichael, Sven Hoffner, and Zahra Hasan
, Kauser Jabeen, Asho Ali, Yasraba Rafiq, Rabia Laiq, Babar Malik, Mahnaz Tanveer, Ramona Groenheit, Solomon Ghebremichael, Sven Hoffner, and Zahra Hasan
Table 2
Spoligotype distribution of 57 extensively drug-resistant strains of Mycobacterium tuberculosis, Pakistan, 2006–2009*
| Genogroup and shared type | No. (%) isolates | Overall % |
|---|---|---|
| CAS | 57.9 | |
| ST21 | 2 (3.5) | |
| ST25 | 1 (1.8) | |
| ST26 | 24 (42.1) | |
| ST428 | 1 (1.8) | |
| ST794 | 1 (1.8) | |
| ST1198 | 3 (5.3) | |
| ST1401 |
1 (1.8) |
|
| Beijing | 8.8 | |
| ST1 |
5 (8.8) |
|
| EAI3 | 1.8 | |
| ST11 |
1 (1.8) |
|
| U | 1.8 | |
| ST346 |
2 (3.5) |
|
| T1 | 7.0 | |
| ST53 | 1 (1.8) | |
| ST804 |
3 (5.3) |
|
| X3 | 1.8 | |
| ST200 |
1 (1.8) |
|
| Unmatched cluster | 2 (3.5) | 3.5 |
| Orphan types | 9 (15.8) | 15.8 |
*ST, spoligotype; CAS, Central Asian strain; EAI, East African Indian strain.
Page created: August 28, 2011
Page updated: August 28, 2011
Page reviewed: August 28, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.